Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis.
Shimada F, Yoshimatsu Y, Sujino T, Fukuda T, Aoki Y, Hayashi Y, Tojo A, Kawaguchi T, Kiyohara H, Sugimoto S, Nanki K, Mikami Y, Miyamoto K, Takabayashi K, Hosoe N, Kato M, Ogata H, Naganuma M, Kanai T. Shimada F, et al. Among authors: naganuma m. Sci Rep. 2024 Mar 9;14(1):5778. doi: 10.1038/s41598-024-56543-y. Sci Rep. 2024. PMID: 38459203 Free PMC article.
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Ikoma T, Matsumoto T, Boku S, Motoki Y, Kinoshita H, Kosaka H, Kaibori M, Inoue K, Sekimoto M, Fujisawa T, Iwai H, Naganuma M, Tanizaki H, Hisamatsu Y, Okada H, Kurata T. Ikoma T, et al. Among authors: naganuma m. Cancer Immunol Immunother. 2024 May 11;73(7):126. doi: 10.1007/s00262-024-03707-4. Cancer Immunol Immunother. 2024. PMID: 38733406 Free PMC article.
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).
Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T, Nojima M, Matsumoto T; DIAMOND2 Study Group. Hisamatsu T, et al. Among authors: naganuma m. J Gastroenterol. 2019 Oct;54(10):860-870. doi: 10.1007/s00535-019-01582-w. Epub 2019 Apr 30. J Gastroenterol. 2019. PMID: 31041545 Clinical Trial.
Fusobacterium Detected in Barrett's Esophagus and Esophageal Adenocarcinoma Tissues.
Tahara T, Shijimaya T, Yamazaki J, Kobayashi S, Horitani A, Matsumoto Y, Nakamura N, Okazaki T, Takahashi Y, Tomiyama T, Honzawa Y, Fukata N, Fukui T, Naganuma M. Tahara T, et al. Among authors: naganuma m. Cancer Invest. 2024 Jul;42(6):469-477. doi: 10.1080/07357907.2024.2359980. Epub 2024 Jun 24. Cancer Invest. 2024. PMID: 38913915
Injury to the Muscle Layer and Risk of Non-cardiac Chest Pain after Endoscopic Submucosal Dissection for Esophageal Cancer.
Tahara T, Shijimaya T, Nishimon S, Kobayashi S, Matsumoto Y, Nakamura N, Okazaki T, Takahashi Y, Tomiyama T, Honzawa Y, Fukata N, Fukui T, Naganuma M. Tahara T, et al. Among authors: naganuma m. J Gastrointestin Liver Dis. 2024 Mar 29;33(1):25-29. doi: 10.15403/jgld-5133. J Gastrointestin Liver Dis. 2024. PMID: 38386890 Free article.
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, Hamada K, Kitamoto H, Kuwada T, Uza N, Sakatani A, Fujii T, Ohno M, Matsuura M, Shibuya T, Ohmiya N, Ooi M, Hoshi N, Moriya K, Tsuchiya K, Yamaguchi Y, Kunisaki R, Takahara M, Takagi T, Takehara T, Hirai F, Kakimoto K, Esaki M, Nakase H, Kinjo F, Torisu T, Kanmura S, Narimatsu K, Matsuoka K, Hiraga H, Yokoyama K, Honzawa Y, Naganuma M, Saruta M, Kodama Y, Chiba T, Seno H. Okabe M, et al. Among authors: naganuma m. J Gastroenterol. 2024 Dec 27. doi: 10.1007/s00535-024-02203-x. Online ahead of print. J Gastroenterol. 2024. PMID: 39729094 No abstract available.
472 results